BIOMAT Database Logo BIOMAT Database Logo

Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. 1996

P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Institute of Respiratory Diseases, University of Siena, Italy.

Bronchial overproduction of leukotrienes and inhibition of prostaglandin synthesis are involved in the pathogenesis of aspirin-induced asthma. We investigated whether inhaled prostaglandin E2 (PGE2) attenuates the response to bronchial challenge with lysine acetylsalicylate (LASA) and the associated increase in urinary leukotriene E4 (u-LTE4) in seven aspirin-sensitive subjects with asthma. Each subject performed two challenges with a single dose of LASA that caused a decrease in FEV1 of 20% or more in a preliminary test, immediately after inhaling 100 micrograms PGE2 in 4 ml saline or placebo, according to a randomized double-blind protocol. FEV1 was recorded at 30-min intervals for 4 h. u-LTE4 was measured by combined high-performance liquid chromatography enzyme immunoassay at 2-h intervals. After placebo, LASA caused an obstructive reaction in all patients, with a maximum decrease in FEV1 of 35 +/- 5% with respect to baseline. u-LTE4 rose from 911 +/- 261 picograms (pg)/mg creatinine at baseline to a maximum value of 2249 +/- 748 after challenge. Inhaled PGE2 provided almost complete protection in all patients. Baseline u-LTE4 was 883 +/- 243 pg/mg creatinine and did not change significantly during the test, reaching a maximum value of 864 +/- 290 (p < 0.05 versus placebo). These results confirm that PGE2 is highly effective in preventing aspirin-induced asthma and suggest that this effect is mediated by inhibition of sulfidopeptide leukotriene production.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol

Related Publications

P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
February 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma.
April 1994, Lancet (London, England),
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma.
February 1994, Lancet (London, England),
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma.
December 1998, The Journal of allergy and clinical immunology,
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics.
October 1994, The European respiratory journal,
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Inhaled verapamil-induced bronchoconstriction in mild asthma.
July 1991, Chest,
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
September 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects.
May 1994, American journal of respiratory and critical care medicine,
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
Increased urinary LTE4 excretion following inhalation of LTC4 and LTE4 in asthmatic subjects.
May 1994, The European respiratory journal,
P Sestini, and L Armetti, and G Gambaro, and M G Pieroni, and R M Refini, and A Sala, and A Vaghi, and G C Folco, and S Bianco, and M Robuschi
The influence of misoprostol (synthetic analogue of prostaglandin E1) on aspirin-induced bronchoconstriction in aspirin-sensitive asthma.
January 1996, Journal of investigational allergology & clinical immunology,
Copied contents to your clipboard!